GB1301738A - - Google Patents

Info

Publication number
GB1301738A
GB1301738A GB3111170A GB3111170A GB1301738A GB 1301738 A GB1301738 A GB 1301738A GB 3111170 A GB3111170 A GB 3111170A GB 3111170 A GB3111170 A GB 3111170A GB 1301738 A GB1301738 A GB 1301738A
Authority
GB
United Kingdom
Prior art keywords
boc
trp
phe
ome
met
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3111170A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1301738A publication Critical patent/GB1301738A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • C07K14/6955Corticotropin [ACTH] with at least 1 amino acid in D-form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1301738 Peptides ORGANON LABORATORIES Ltd 26 June 1970 [9 July 1969] 31111/70 Heading C2C Compounds of the formula: X-Met-Glu (or Csln)-His-D-Phe-Arg (or Lys)-Trp-Y(I) where X is H, H-Ser or H-Gly; Y is OH or Gly-OH and where Met- and -Ser are in either the L- or D- forms and their salts, complexes, amides and esters are prepared by methods known for the preparation of peptide. The following compounds are prepared as starting materials and intermediates: BOCMet-Glu(OtBu)OEt and its hydrazide; BOC-DMet-Glu(OtBu)OEt and its hydrazide; BOCGly-Met-OMe and its hydrazide; BOC-Ser-Met- OMe and its hydrazide; BOC-D-Ser-OMe and its hydrazide; BOC-Ser-Met-Glu(OtBu)OEt and its hydrazide; BOC-D-Sri-Met-Glu(OtBu)NHNH 2 ; BOC - Gly-Met - Glu(OtBu)NHNH 2 ; Trit(Trit) His-D-Phe-Arg-Trp OMe and the free acid; Trit- (Trit)His-D-Phe-Arg-Trp NHNH 2 , Trit(Trit)- His-D-Phe-Arg-Trp-Gly OH, HCl and its hexadecylester; glycine hexadecyl ester HCl; H-His- D-Phe-Arg-Trp OH; H-His-D-Phe-Arg-Trp-Gly OH and its hexadecyl ester; Z-(BOC)Lys-Trp OMe; H-(BOC)Lys-Trp OMe; Z-His-D-Phe- (BOC)Lys.Trp OMe; H-His-D-Phe-(BOC)Lys- Trp OMe and BOC-Met-aiu(OtBu)-His-D-Phe- Arg-Tro-Gly OH. Pharmaceutical compositions in forms for enteral and parenteral administration contain compounds (I) and have psychophaimacological activity.
GB3111170A 1969-07-09 1970-06-26 Expired GB1301738A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84051869A 1969-07-09 1969-07-09

Publications (1)

Publication Number Publication Date
GB1301738A true GB1301738A (en) 1973-01-04

Family

ID=25282580

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3111170A Expired GB1301738A (en) 1969-07-09 1970-06-26

Country Status (8)

Country Link
JP (1) JPS4843351B1 (en)
CH (1) CH553162A (en)
DE (1) DE2033703A1 (en)
DK (1) DK128531B (en)
FR (1) FR2059499B1 (en)
GB (1) GB1301738A (en)
HU (1) HU163599B (en)
NL (1) NL7010052A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7203042A (en) * 1972-03-08 1973-09-11
NL175988C (en) * 1972-05-24 1985-02-01 Akzo Nv PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH A PSYCHOPHARMACOLOGICAL EFFECT, THAT A PEPTIDE OR PEPTIDE DERIVATIVE DERIVED FROM AN AMINO ACIDS 4-10, FRAGMENT OF ADRENOCORTICOTROP HORMONE, AS AN PROPERTY, AND ITS PROPERTY, PROPERTY, AND ITS PROPERTY.

Also Published As

Publication number Publication date
DK128531B (en) 1974-05-20
CH553162A (en) 1974-08-30
FR2059499A1 (en) 1971-06-04
DE2033703A1 (en) 1971-01-21
JPS4843351B1 (en) 1973-12-18
HU163599B (en) 1973-09-27
NL7010052A (en) 1971-01-12
FR2059499B1 (en) 1974-03-22

Similar Documents

Publication Publication Date Title
ES8203385A1 (en) N-(vinblastinoyl-23) derivatives of amino acids and peptides and their preparation.
GB1443281A (en) Pharmaceutically active peptides and method of use thereof
GB1329860A (en) Process for the manufacture of peptides containing cystine
AU497035B2 (en) Administering amino acid ackyl esters
GB1301738A (en)
GB1309150A (en) Acthactive peptides and process for their manufacture
ES272025A1 (en) Heneicosapeptides and intermediates for the manufacture thereof
CA1023664A (en) Composition and method for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy-acid analogs of amino acids
GB1158726A (en) Amino Acid Derivatives
IL43056A (en) Peptides having acth activity containing alpha-aminooxy carboxylic acids on both terminal groups and a process for the preparation thereof
GB1322112A (en) 3,4,5-trimethoxybenzoic acid derivatives and their uses
GB1309728A (en) Hepta-octa-and nona peptides
GB1292898A (en) New polypeptides and process for their manufacture
ES417951A1 (en) Peptides of ACTH activity containing {60 -aminooxy carboxylic acid on the N-terminal moiety, and a process for the preparation thereof
GB1329618A (en) Peptides having adrenocorticotropic activity and process for their preparation
GB1353827A (en) Acthaction peptides and process for their manufacture
GB1329869A (en) Tetracycline derivatives
GB1210551A (en) New peptides having an acth-activity and process for their manufacture
GB1044144A (en) Process for the manufacture of a polypeptide
GB1314051A (en) Polypeptides and their derivatives
ES350237A1 (en) Complexes of a.c.t.h. peptides and polyphosphoric acids
GB1525664A (en) Tripeptides derived from phenylalanine and histidine their preparation and use
UPSON The synthesis of specifically deuterated amino acids and pertides for use in biophysical studies[Ph. D. Thesis]
GB1363801A (en) Peptides and their preparation
GB1320298A (en) Peptides

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees